P-gp/BCRP-IN-1 is a potential, relatively safe, and orally effective inhibitor of efflux transporters (P-gp and BCRP); it reverses drug resistance by inhibiting the efflux function of P-gp and BCRP, overcomes paclitaxel resistance, and enhances the oral bioavailability of paclitaxel.